Title of the Congress : |
Asia Pacific Association of Medical Toxicology 12th International Congress |
Title of your Abstract : |
Determination of tramadol and its major metabolites (M1, M2 and M5) concentration in plasma of human poisoning by HPLC and its relation with clinical symptoms |
country : |
Dobai |
From : |
Thursday, November 21, 2013 |
To : |
Saturday, November 23, 2013 |
Abstract(Please copy/paste the abstract send to the congress) : |
Tramadol hydrochloride is a novel synthetic opioid morphine like with a centrally acting analgesic effect. Tramadol produces analgesia by binding weakly to the µ-opioid receptor and inhibits reuptake of monoaminergic hormones (norepinephrine and serotonin). It is rapidly metabolized in the liver into O-desmethyl-tramadol (M1), N-desmethyl-tramadol (M2) and N,O-didesmethyl-tramadol (M5). CYP2D6 primarily is involved in M1 formation, CYP2B6 and 3A4 are involved in M2 formation and CYP 2D6, CYP 2B6 and 3A4 are involved in M5 formation. The CYP2D6 has high genetic polymorphism affecting the CYP enzymes in human and any co-ingested drug with potential effect on CYP2D6 such as tricyclic antidepressants, phenothiazines, and selective serotonin reuptake inhibitors may affect blood levels of M1. The pharmacological activity of M1 is most important and more potent at the µ -receptor than parent drug tramadol.
The main and common side effects of tramadol include nausea, vomiting, vertigo, drowsiness, fatigue, sweating, dry mouth, and in over dose tachycardia, CNS depression, respiratory depression, seizure and coma. The serious side effect of tramadol may be depended to genetics, renal failure and metabolism. Although tramadol-related seizure may be happened with over dose, several reports showed that it could be occurred even at therapeutic doses. The exact cause and mechanism of induction of seizure in some users of tramadol remains unclear yet.
In this study blood samples of 120 patients with a history of tramadol intoxication who were admitted in the emergency department of Logman Hakim Hospital were collected. Tramadol and its major metabolites (M1, M2, and M5) concentrations were measured by high performance liquid chromatography (HPLC) methods with fluorescence detection. Furthermore tramadol and its major metabolites (M1, M2, and M5) concentrations were correlated with the main symptoms.
Of all the symptoms, which were investigated, only seizure had significant correlation with respect to sex and increase concentration. Male patients had seizure significantly greater than females (p <0.001). It was also shown that the average concentration of M2 in male is significantly greater than female (p=0.003). Our results also indicates that there is a significant correlation between increased tramadol (p=0.006) and its metabolites (M1; p=0.017, M2; p=0.023, M5; p=0.011) concentrations in plasma with respect to seizure symptom. Also with increasing ratio of M1/M2, decreased in the risk of seizure (0.26-fold, p=0.02) was found.
It is concluded that there might be a relationship between tramadol and its metabolites plasma concentrations with regard to sex and seizure. Also the risk of seizure increases with increasing concentration. |
Keywords of your Abstract : |
tramadol, major metabolites, clinical symptoms |
Acceptance Letter : |
http://gsia.tums.ac.ir/images/UserFiles/11668/Forms/306/acceptance_letter.pdf |
The presentation : |
Oral |
The Cover of Abstract book : |
http://gsia.tums.ac.ir/images/UserFiles/11668/Forms/306/scan book Copy_1.pdf |
Published abstract in the abstract book with the related code : |
http://gsia.tums.ac.ir/images/UserFiles/11668/Forms/306/scan_abstract_Copy.pdf |
Where has your abstract been indexed? : |
none |
If you choose other, please name : |
|